Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1981 2
1983 1
1986 1
1987 2
1989 1
1990 3
1992 1
1994 1
1996 1
1998 1
2004 1
2006 3
2007 2
2009 5
2010 3
2011 3
2013 1
2014 1
2015 1
2016 4
2017 5
2019 3
2020 1
2021 5
2022 7
2023 9
2024 5
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Nutrition, Physical Activity and Supplementation in Irritable Bowel Syndrome.
Radziszewska M, Smarkusz-Zarzecka J, Ostrowska L. Radziszewska M, et al. Nutrients. 2023 Aug 21;15(16):3662. doi: 10.3390/nu15163662. Nutrients. 2023. PMID: 37630852 Free PMC article. Review.
Irritable Bowel Syndrome (IBS) is a chronic, recurrent functional disorder of the intestine diagnosed based on the Rome IV criteria. ...Attention is drawn to the use of probiotics, vitamin D, and psyllium husk/ispaghula. This review aims to analyze the
Irritable Bowel Syndrome (IBS) is a chronic, recurrent functional disorder of the intestine diagnosed based on the Rome
The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. Clinical use of psyllium husk in the treatment of irritable bowel syndrome, ulcerative colitis, and colorectal cancer.
Przybyszewska J, Kuźmiński A, Przybyszewski M, Popławski C. Przybyszewska J, et al. Prz Gastroenterol. 2024;19(2):121-126. doi: 10.5114/pg.2024.139209. Epub 2024 Apr 29. Prz Gastroenterol. 2024. PMID: 38939069 Free PMC article. Review.
The results of clinical trials demonstrate the therapeutic efficacy of psyllium husk for various gastrointestinal disorders. It has also been documented that psyllium ingestion exhibits antioxidant, immunomodulatory, antiproliferative, anticancer, and antiviral effe …
The results of clinical trials demonstrate the therapeutic efficacy of psyllium husk for various gastrointestinal disorders. It has a …
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial.
Gearry R, Fukudo S, Barbara G, Kuhn-Sherlock B, Ansell J, Blatchford P, Eady S, Wallace A, Butts C, Cremon C, Barbaro MR, Pagano I, Okawa Y, Muratubaki T, Okamoto T, Fuda M, Endo Y, Kano M, Kanazawa M, Nakaya N, Nakaya K, Drummond L. Gearry R, et al. Am J Gastroenterol. 2023 Jun 1;118(6):1058-1068. doi: 10.14309/ajg.0000000000002124. Epub 2022 Dec 20. Am J Gastroenterol. 2023. PMID: 36537785 Free PMC article. Clinical Trial.
METHODS: Participants included healthy controls (n = 63), patients with functional constipation (FC, n = 60), and patients with constipation-predominant irritable bowel syndrome (IBS-C, n = 61) randomly assigned to consume 2 green kiwifruits or psyllium
METHODS: Participants included healthy controls (n = 63), patients with functional constipation (FC, n = 60), and patients with constipation …
Drugs for Irritable Bowel Syndrome.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Mar 23;62(1594):25-32. Med Lett Drugs Ther. 2020. PMID: 32324172 No abstract available.
Drugs for irritable bowel syndrome.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2025 Feb 3;67(1721):17-24. doi: 10.58347/tml.2025.1721a. Med Lett Drugs Ther. 2025. PMID: 39912839 No abstract available.
Irritable bowel syndrome and diet: where are we in 2018?
Dimidi E, Rossi M, Whelan K. Dimidi E, et al. Curr Opin Clin Nutr Metab Care. 2017 Nov;20(6):456-463. doi: 10.1097/MCO.0000000000000416. Curr Opin Clin Nutr Metab Care. 2017. PMID: 28872467 Review.
PURPOSE OF REVIEW: The aim is to review the most recent advances in the evidence supporting the use of various dietary interventions for the management of irritable bowel syndrome (IBS). RECENT FINDINGS: There is insufficient evidence of the effect of fibres …
PURPOSE OF REVIEW: The aim is to review the most recent advances in the evidence supporting the use of various dietary interventions for the …
The role of psyllium fibre supplementation in treating irritable bowel syndrome.
Chouinard LE. Chouinard LE. Can J Diet Pract Res. 2011 Spring;72(1):e107-14. doi: 10.3148/72.1.2011.48. Can J Diet Pract Res. 2011. PMID: 21382232
North American family physicians and dietitians commonly recommend psyllium fibre supplementation for treating symptoms of irritable bowel syndrome (IBS). ...The results of this systematic review indicate limited and conflicting evidence to support the …
North American family physicians and dietitians commonly recommend psyllium fibre supplementation for treating symptoms of irritab
Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.
Menon J, Thapa BR, Kumari R, Puttaiah Kadyada S, Rana S, Lal SB. Menon J, et al. J Pediatr Gastroenterol Nutr. 2023 Jan 1;76(1):14-19. doi: 10.1097/MPG.0000000000003622. Epub 2022 Sep 22. J Pediatr Gastroenterol Nutr. 2023. PMID: 36136861 Clinical Trial.
OBJECTIVE: Pediatric irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with variable response to various therapeutic agents. Psyllium has been proven to be effective in adults; however, there is no study in children. ...
OBJECTIVE: Pediatric irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with variable resp …
Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.
van Tilburg MAL, Reed B, Benninga M, Chogle A, Chumpitazi BP, DiLorenzo C, Levy R, Nurko S, Rajindrajith S, Saps M, Shulman RJ, Staiano A, Thapar N, Velasco Benitez CA, Vlieger A. van Tilburg MAL, et al. J Pediatr Gastroenterol Nutr. 2023 Aug 1;77(2):e49-e50. doi: 10.1097/MPG.0000000000003814. Epub 2023 Apr 25. J Pediatr Gastroenterol Nutr. 2023. PMID: 37098052 No abstract available.
Treatment of irritable bowel syndrome.
Trinkley KE, Nahata MC. Trinkley KE, et al. J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24. J Clin Pharm Ther. 2011. PMID: 21545610 Review.
WHAT IS KNOWN AND OBJECTIVE: The complexity and diversity of irritable bowel syndrome's (IBS) presentation make treatment difficult. Although there are reviews and guidelines for treating IBS, they focus on the efficacy of medications for IBS symptoms using h …
WHAT IS KNOWN AND OBJECTIVE: The complexity and diversity of irritable bowel syndrome's (IBS) presentation make treatme …
73 results